Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-026337
Filing Date
2021-04-12
Accepted
2021-04-12 15:10:06
Documents
1
Period of Report
2021-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3915
  Complete submission text file 0001209191-21-026337.txt   5269
Mailing Address C/O SGX PHARMACEUTICALS, INC. 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address
GREY MICHAEL G (Reporting) CIK: 0001240122 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40315 | Film No.: 21820520

Mailing Address P.O. BOX 675614 RANCHO SANTA FE CA 92067
Business Address P.O. BOX 675614 RANCHO SANTA FE CA 92067 619-733-3852
Reneo Pharmaceuticals, Inc. (Issuer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations